Ashley Alexander, a certified ophthalmic technician based in Ontario, Canada, discusses the art and science of working with patients in an ophthalmology clinic. Ashley describes the various tests performed by an ophthalmic technician, lessons learned from working in a low vision clinic, and the benefits and drawbacks of working in private practice.

Dr. Robert Greenberg, current Chairman and CEO of the Alfred Mann Foundation and former CEO of Second Sight Medical Products, shares his experience at the helm of one of the world’s most innovative medical device companies. Dr. Greenberg discusses lessons learned while working at the FDA and the Alfred Mann Foundation, as well as challenges faced while building the world’s most advanced retinal implant to treat patients with Retinitis Pigmentosa.

Ophthalmologist Dr. Debra-Meghan Sanft shares a basic overview of the causes, risk factors, and treatments associated with an array of ocular emergencies, including corneal ulcers, acute angle closure glaucoma, vascular occlusion, giant cell arteritis, retinal tears and detachment, and ocular trauma.

Dr. Walter Wittich discusses his role as chair of Deafblind International Research Network, highlighting the purpose of the organization, and how it is serving people across the globe. Dr. Wittich further explores the realm of low vision rehabilitation, including his journey in the field, current gaps in communication and training, and what the future of the field might look like and the unique challenges it may face. 

Dr. Lore Thaler, Lecturer at Durham University in the Department of Psychology, shares stories about the science of echolocation, including insights from her own research involving brain imaging. Dr. Thaler discusses how anybody can learn to echolocate, why certain types of sounds are more commonly used, how her research is shaping our understanding of the way humans learn, and much more.

Dr. Julie Burnier, Assistant Professor of Oncology and Pathology at McGill university, explains how liquid biopsies can provide critical information about ocular tumours including genetic signature, presence of circulating tumour cells, and other biomarkers of disease severity. Dr. Burnier discusses Uveal Melanoma, the most common intraocular tumour in adults, and how liquid biopsies are becoming front and center in the personalized management of this highly complex tumour.

Ricardo Wagner, Accessibility Lead for Microsoft Canada, shares inspirational stories of how inclusive design has influenced a global community of people with accessibility needs, including those with low vision. From the surgeon who could access a computer hands free to an artist with ALS who was able to continue creating using only her eyes, the broad-reaching, life changing impacts of Microsoft’s accessibility endeavours comes to light in this thought provoking interview.

Will Butler, VP at "Be My Eyes", talks about the popular smart phone app and its rapid global adoption among the blind and visually impaired as well as millions of volunteers. Will further shares stories of corporate partnerships established by Be My Eyes to help people with low vision navigate everything from performing computer updates to reading pregnancy test results.